FDA accepted BridgeBio’s encaleret NDA, granting Priority Review and setting a May 8, 2027 target action date; RECLAIM-HP has ...
From Oct. 7–11, the program included an NBA coach-led clinic for Macau Special Olympics members, a school visit and Greater ...
Stock market news for October 11, 2026. Press releases, financial news, and business developments from public companies with ...
More than 6,400 outside personnel are helping; crews and contractors from 25 states support restoration in hardest-hit ...
About two-thirds of eligible patients required no retreatment after 16 weeks; the FDA accepted Roche's application, with an ...
The PHLX Semiconductor Index was up 73% year to date in late September; higher Treasury yields and crude oil prices also ...
Webull revenue rose 51% year over year to $198.8M; Futu's total revenue rose 35.6% year over year to US$918.2M. Robinhood's ...
Adverse events tied to proliferative diabetic retinopathy affected 6.7% and 6.1% of remigromig patients, versus 0.9% with ranibizumab; BAROLO continues.
Power outages account for most network disruptions; automated systems made more than 7,500 adjustments since Oct. 9 as crews ...
Astrana Health has over 20,000 in-network providers. Verda Noble Care's open enrollment runs Oct. 15-Dec. 7; its chronic-care ...
vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
Among 429 adults using automated insulin delivery, 24% reported frequent low blood sugar; 12% reported a Level 3 event in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results